Migraine treatment and placebo effect

References

• Ernst E. A historical perspective on placebo. Clin. Med.8(1), 9–10 (2008).
   PubMedGoogle Scholar
• Thompson WG. Placebos: a review of the placebo response. Am. J. Gastroenterol.95(7), 1637–1643 (2000).
   PubMed Web of Science ®Google Scholar
• Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron59(2), 195–206 (2008).
   PubMed Web of Science ®Google Scholar
• Diener HC, Schorn CF, Bingel U, Dodick DW. The importance of placebo in headache research. Cephalalgia28(10), 1003–1011 (2008).
   PubMed Web of Science ®Google Scholar
• Bostick NA, Sade R, Levine MA, Stewart DM Jr. Placebo use in clinical practice: report of the American Medical Association Council on Ethical and Judicial Affairs. J. Clin. Ethics19(1), 58–61 (2008).
   PubMed Web of Science ®Google Scholar
• Cahana A, Romagnioli S. Not all placebos are the same: a debate on the ethics of placebo use in clinical trials versus clinical practice. J. Anesth.21(1), 102–105 (2007).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Goadsby PJ. Double-blind clinical trials of oral triptans vs other classes of acute migraine medication – a review. Cephalalgia24(5), 321–332 (2004).
   PubMed Web of Science ®Google Scholar
• Haour F. Mechanisms of the placebo effect and of conditioning. Neuroimmunomodulation12(4), 195–200 (2005).
   PubMedGoogle Scholar
• Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA271(20), 1609–1614 (1994).
   PubMed Web of Science ®Google Scholar
• Fillingim RB, Price DD. What is controlled for in placebo-controlled trials?. Mayo Clin. Proc.80(9), 1119–1121 (2005).
   PubMedGoogle Scholar
• Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK. Neurobiological mechanisms of the placebo effect. J. Neurosci.25(45), 10390–10402 (2005).
   PubMed Web of Science ®Google Scholar
• Voudouris NJ, Peck CL, Coleman G. Conditioned placebo responses. J. Pers. Soc. Psychol.48(1), 47–53 (1985).
   PubMed Web of Science ®Google Scholar
• Colagiuri B, Morley K, Boakes R, Haber P. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence. Psychother. Psychosom.78(3), 167–171 (2009).
   PubMed Web of Science ®Google Scholar
• Pollo A, Benedetti F. The placebo response: neurobiological and clinical issues of neurological relevance. Prog. Brain Res.175, 283–294 (2009).
   PubMed Web of Science ®Google Scholar
• Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J. Neurosci.19, 484–494 (1999).
   PubMed Web of Science ®Google Scholar
• Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science295, 1737–1740 (2002).
   PubMed Web of Science ®Google Scholar
• Faria V, Fredrikson M, Furmark T. Imaging the placebo response: a neurofunctional review. Eur. Neuropsychopharmacol.18(7), 473–485 (2008).
   PubMed Web of Science ®Google Scholar
• Kleijnen J, de Craen AJ, van Everdingen J, Krol L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet344(8933), 1347–1349 (1994).
   PubMed Web of Science ®Google Scholar
• Finniss DG, Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain114(1–2), 3–6 (2005).
   PubMed Web of Science ®Google Scholar
• Koshi EB, Short CA. Placebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Pract.7(1), 4–20 (2007).
   PubMedGoogle Scholar
• Loder E, Goldstein R, Biondi D. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls. Cephalalgia25(2), 124–131 (2005).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Bordini CA, Sheftell FD, Speciali JG, Bigal JO. Migraine with aura versus migraine without aura: pain intensity and associated symptom intensities after placebo. Headache42(9), 872–877 (2002).
   PubMedGoogle Scholar
• Vecsei L, Gallacchi G, Sagi I et al. Diclofenac epolamine is effective in the treatment of acute migraine attacks. A randomized, crossover, double blind, placebo-controlled, clinical study. Cephalalgia27(1), 29–34 (2007).
   PubMed Web of Science ®Google Scholar
• Rheims S, Cucherat M, Arzimanoglou A, Ryvlin P. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med.5(8), e166 (2008).
   PubMedGoogle Scholar
• Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs60(6), 1259–1287 (2000).
   PubMed Web of Science ®Google Scholar
• Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM. Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases. Headache44(8), 794–800 (2004).
   PubMed Web of Science ®Google Scholar
• Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu. Rev. Psychol.59, 565–590 (2008).
   PubMed Web of Science ®Google Scholar
• Saxena PR, Tfelt-Hansen P. Triptans, 5-HT 1B/1D receptor agonists in the acute treatment of migraines. In: The Headaches. Olesen J, Goadsby PJ, Tfelt-Hansen P, Welch KM (Eds). Lippincott, Williams & Wilkins, PA, USA 469–475 (2006).
   Google Scholar
• Goldstein J, Silberstein SD, Saper JR, Ryan RE Jr, Lipton RB. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache46(3), 444–453 (2006).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M. Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study. Arch. Intern. Med.160(22), 3486–3492 (2000).
   PubMed Web of Science ®Google Scholar
• Diener HC, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T et al. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia24(11), 947–954 (2004).
   PubMed Web of Science ®Google Scholar
• Amanzio M, Corazzini LL, Vase L, Benedetti F. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain146(3), 261–269 (2009).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Saper JR, Silberstein SD et al. Migraine prophylaxis with divalproex. Arch. Neurol.52, 281–286 (1995).
   PubMed Web of Science ®Google Scholar
• Klapper J; on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia17, 103–108 (1997).
   PubMed Web of Science ®Google Scholar
• Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia16, 257–263 (1996).
   PubMed Web of Science ®Google Scholar
• van de Ven LLM, Franke CL, Koehler PJ; on Behalf of the Investigators. Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study. Cephalalgia17, 596–599 (1997).
   PubMed Web of Science ®Google Scholar
• Diener H, Krupp P, Schmitt T et al. Cyclandelate in the prophylaxis of migraine: a placebo-controlled study. Cephalalgia21, 66–70 (2001).
   PubMed Web of Science ®Google Scholar
• Macedo A, Banos JE, Farre M. Placebo response in the prophylaxis of migraine: a meta-analysis. Eur. J. Pain12, 68–75 (2008).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache45, 293–307 (2005).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Gobel H, Jensen R et al. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia26, 790–800 (2006).
   PubMed Web of Science ®Google Scholar
• Linde K, Streng A, Jurgens S et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA293, 2118–2125 (2005).
   PubMed Web of Science ®Google Scholar
• Diener HC, Kronfeld K, Boewing G et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol.5, 310–316 (2006).
   PubMed Web of Science ®Google Scholar
• Bausell RB, Lao L, Bergman S, Lee WL, Berman BM. Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants’ perceived assignments in two placebo-controlled trials. Eval. Health Prof.28, 9–26 (2005).
   PubMed Web of Science ®Google Scholar